FDA Approves First Gene Therapy for Children with Metachromatic Leukodystrophy
For Immediate Release: March 18, 2024 Today, the U.S. Food and Drug Administration approved Lenmeldy (atidarsagene autotemcel), the first FDA-approved gene therapy indicated for the treatment of children with pre-symptomatic late infantile, pre-symptomatic …